Stocks
Biogen (BIIB) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 340.6% | 723.3% | 848.2% | 917.4% | 790.6% | 630.7% | |||
| Changes by years, y/y, % | +48pp | +383pp | +125pp | +69pp | -127pp | +22.0% | |||
Biogen. R&D/CAPEX, %
Biogen. R&D/CAPEX, changes, pp
Biogen (BIIB) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 796.9% | 671.5% | 840.5% | 875.6% | 317.3% | 630.7% | ||
| Changes by years, y/y, % | -156pp | -691pp | -89pp | +187pp | -480pp | |||
| Changes by quarters, q/q, % | +109pp | -125pp | +169pp | +35pp | -558pp | |||
